Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Regenerative Sportscare Institute (RSI) is a specialized medical facility focused on non-surgical, regenerative treatments for orthopedic and sports-related injuries. Led by Dr. Gregory Lutz, a pioneer in the field of regenerative sports medicine, the institute utilizes advanced biologics such as platelet-rich plasma (PRP) and bone marrow-derived stem cells to treat conditions like degenerative disc disease and joint osteoarthritis. RSI is particularly noted for its clinical expertise in intradiscal regenerative therapies, aiming to restore function and reduce pain without invasive surgery. The institute combines cutting-edge research with clinical practice to provide personalized care for athletes and individuals with chronic musculoskeletal conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Regenerative Sportscare Institute.